Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation.

Bai Y, Ahmad U, Wang Y, Li JH, Choy JC, Kim RW, Kirkiles-Smith N, Maher SE, Karras JG, Bennett CF, Bothwell AL, Pober JS, Tellides G.

J Biol Chem. 2008 Mar 14;283(11):6832-42. doi: 10.1074/jbc.M706021200. Epub 2008 Jan 11.

PMID:
18192275
[PubMed - indexed for MEDLINE]
Free Article
2.

Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.

Lesinski GB, Trefry J, Brasdovich M, Kondadasula SV, Sackey K, Zimmerer JM, Chaudhury AR, Yu L, Zhang X, Crespin TR, Walker MJ, Carson WE 3rd.

Clin Cancer Res. 2007 Sep 1;13(17):5010-9.

PMID:
17785551
[PubMed - indexed for MEDLINE]
Free Article
3.

Interferon: cellular executioner or white knight?

Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM.

Curr Med Chem. 2007;14(12):1279-89. Review.

PMID:
17504213
[PubMed - indexed for MEDLINE]
5.

STAT activation and differential complex formation dictate selectivity of interferon responses.

Wesoly J, Szweykowska-Kulinska Z, Bluyssen HA.

Acta Biochim Pol. 2007;54(1):27-38. Epub 2007 Mar 9. Review.

PMID:
17351669
[PubMed - indexed for MEDLINE]
Free Article
6.

Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.

Wang W, Edington HD, Rao UN, Jukic DM, Land SR, Ferrone S, Kirkwood JM.

Clin Cancer Res. 2007 Mar 1;13(5):1523-31.

PMID:
17332298
[PubMed - indexed for MEDLINE]
Free Article
7.

Functional annotation of IFN-alpha-stimulated gene expression profiles from sensitive and resistant renal cell carcinoma cell lines.

Holko M, Williams BR.

J Interferon Cytokine Res. 2006 Aug;26(8):534-47.

PMID:
16881864
[PubMed - indexed for MEDLINE]
8.

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.

Koch-Henriksen N, Sørensen PS, Christensen T, Frederiksen J, Ravnborg M, Jensen K, Heltberg A, Kristensen O, Stenager E, Petersen T, Hansen T; Danish Multiple Sclerosis Group.

Neurology. 2006 Apr 11;66(7):1056-60. Epub 2006 Mar 1.

PMID:
16510769
[PubMed - indexed for MEDLINE]
9.

Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.

Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, Takahashi-Fujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T, Sugano S.

Genome Res. 2006 Jan;16(1):55-65. Epub 2005 Dec 12.

PMID:
16344560
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells.

Liedtke C, Gröger N, Manns MP, Trautwein C.

J Hepatol. 2006 Feb;44(2):342-9. Epub 2005 Aug 2.

PMID:
16225956
[PubMed - indexed for MEDLINE]
11.

Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy.

Lesinski GB, Valentino D, Hade EM, Jones S, Magro C, Chaudhury AR, Walker MJ, Carson WE 3rd.

Cancer Immunol Immunother. 2005 Sep;54(9):815-25. Epub 2005 Jan 25.

PMID:
15668815
[PubMed - indexed for MEDLINE]
12.

A BAF-centred view of the immune system.

Chi T.

Nat Rev Immunol. 2004 Dec;4(12):965-77. Review.

PMID:
15573131
[PubMed - indexed for MEDLINE]
13.

Interferon-alpha: regulatory effects on cell cycle and angiogenesis.

Rosewicz S, Detjen K, Scholz A, von Marschall Z.

Neuroendocrinology. 2004;80 Suppl 1:85-93.

PMID:
15477724
[PubMed - indexed for MEDLINE]
14.

The chromatin-remodeling BAF complex mediates cellular antiviral activities by promoter priming.

Cui K, Tailor P, Liu H, Chen X, Ozato K, Zhao K.

Mol Cell Biol. 2004 May;24(10):4476-86.

PMID:
15121865
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.

Badgwell B, Lesinski GB, Magro C, Abood G, Skaf A, Carson W 3rd.

J Surg Res. 2004 Jan;116(1):129-36.

PMID:
14732359
[PubMed - indexed for MEDLINE]
16.

DBTSS, DataBase of Transcriptional Start Sites: progress report 2004.

Suzuki Y, Yamashita R, Sugano S, Nakai K.

Nucleic Acids Res. 2004 Jan 1;32(Database issue):D78-81.

PMID:
14681363
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Interferons: mechanisms of action and clinical applications.

Parmar S, Platanias LC.

Curr Opin Oncol. 2003 Nov;15(6):431-9. Review.

PMID:
14624225
[PubMed - indexed for MEDLINE]
18.

Interferon-gamma: an overview of signals, mechanisms and functions.

Schroder K, Hertzog PJ, Ravasi T, Hume DA.

J Leukoc Biol. 2004 Feb;75(2):163-89. Epub 2003 Oct 2. Review.

PMID:
14525967
[PubMed - indexed for MEDLINE]
Free Article
19.

Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein.

Geiss GK, Carter VS, He Y, Kwieciszewski BK, Holzman T, Korth MJ, Lazaro CA, Fausto N, Bumgarner RE, Katze MG.

J Virol. 2003 Jun;77(11):6367-75.

PMID:
12743294
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).

Chawla-Sarkar M, Leaman DW, Jacobs BS, Tuthill RJ, Chatterjee-Kishore M, Stark GR, Borden EC.

J Interferon Cytokine Res. 2002 May;22(5):603-13.

PMID:
12060499
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk